ArticleFrontiers in cardiovascular medicine2025
Analysis of risk factors and the predictive value of a nomogram model for coronary heart disease in patients with rheumatoid arthritis.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rheumatoid arthritis (RA) is associated with an elevated risk of coronary heart disease (CHD) due to a complex interplay of traditional cardiovascular risk factors and RA-specific mechanisms. This study aimed to identify key risk factors for CHD in RA patients and develop a nomogram model for individualized risk prediction. Methods: A retrospective study was conducted involving 258 RA patients, including 32 with CHD and 226 without CHD, admitted between January 2021 and August 2024. Demographic, clinical, and laboratory data were collected. Multivariate logistic regression analysis identified independent risk factors, which were incorporated into a nomogram model. The model's performance was evaluated using the receiver operating characteristic (ROC) curve, calibration plots, and decision curve analysis (DCA). Internal validation was performed using bootstrap resampling. Results: Key risk factors for CHD in RA patients included hypertension, HbA1c, RA duration, carotid plaque burden, uric acid, and ECG abnormalities. The nomogram demonstrated excellent discriminative ability, with an area under the ROC curve (AUC) of 0.868 (95% CI: 0.819-0.916) and robust calibration ( Conclusions: This study identified hypertension, elevated HbA1c, prolonged RA duration, carotid plaque burden, increased uric acid levels, and ECG abnormalities as significant risk factors for CHD in RA patients. A nomogram prediction model incorporating these factors was developed, exhibiting outstanding discriminatory and calibration capabilities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.